# Error Analysis

## Objective
The objective of this analysis is to evaluate the prediction performance of the Adaptive Neural Network on the Chronic Kidney Disease (CKD) dataset and investigate the misclassified samples.

## Methodology
The trained Adaptive Neural Network was evaluated using the held-out test dataset. Predicted labels were compared with the actual class labels to identify:

- False Positives (FP)
- False Negatives (FN)

The confusion matrix and classification metrics were used to assess the model performance.

## Results
- Total Test Samples: 80
- False Positives: 1
- False Negatives: 1

The confusion matrix was:

```
[[49  1]
 [ 1 29]]
```

## Observations
The Adaptive Neural Network correctly classified 78 out of 80 test samples, achieving an overall accuracy of 97.5%.
One CKD patient was incorrectly classified as non-CKD (False Negative), while one healthy patient was incorrectly classified as CKD (False Positive).
The false negative represents a clinically important case because the patient may not receive timely diagnosis and treatment. The false positive may result in additional diagnostic tests, but it is generally less critical than missing a true CKD patient.
Overall, the small number of prediction errors indicates that the model generalizes well on the CKD dataset while maintaining high sensitivity and specificity.

## Discussion
The misclassified samples likely represent borderline clinical cases with feature values that overlap between CKD and non-CKD patients. Such cases are naturally more difficult to classify accurately.
Possible reasons for these prediction errors include:
- Mild or early-stage CKD with less distinctive clinical characteristics.
- Overlapping laboratory measurements between healthy and CKD patients.
- Limited dataset size.
- Natural variability in patient clinical measurements.

## Clinical Significance
Accurate detection of CKD is essential because delayed diagnosis may result in disease progression and reduced treatment effectiveness.
Although the proposed Adaptive Neural Network achieved excellent predictive performance, the presence of one false negative highlights the importance of further improving model sensitivity for clinical applications.

## Conclusion
The proposed Adaptive Neural Network demonstrated strong generalization performance on the CKD dataset with an accuracy of 97.5% and only two misclassified samples. The low number of prediction errors indicates that the model is robust and reliable for CKD prediction. Future work should evaluate the model on larger and more diverse clinical datasets and investigate explainable AI techniques to better understand difficult prediction cases.